Comparative analysis of Sildenafil and Tadalafil in erectile dysfunctio
- Conditions
- Health Condition 1: - Health Condition 2: N529- Male erectile dysfunction, unspecifiedHealth Condition 3: N529- Male erectile dysfunction, unspecified
- Registration Number
- CTRI/2023/01/048951
- Lead Sponsor
- ot applicable
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Diagnosed with erectile dysfunction as per the ICD-11 criteria.
2.Participants willing to provide informed written consent for participation.
3.Participants in the age group of 21-50 years
4.Participants with adequate literacy to complete the diary card and questionnaires evaluation.
5.Participants must be staying with his spouse for a minimum period of six months and anticipate having the same adult female sexual partner during the study.
6.Participants must not have received Sildenafil or Tadalafil in the past one month.
1.Participants taking organic nitrates for any reason.
2.Participants having a history of unstable angina,cardiac stents,or life threatening arrythmias.
3.Participants with a history of primary hypoactive sexual desire disorder.
4.Erectile dysfunction due to spinal cord injury.
5.Any clinical history of structural deformity causing erectile dysfunction.
6.Participants with a history of undergoing prostate surgery e.g. radical prostatectomy.
7.Participants with a clinical history of treated or untreated hypogonadism.
8.Participants with below normal serum testosterone levels.
9.Participants with a major co-morbid mental illness (i.e. schizophrenia and bipolar
disorder).
10.Participants with a history of hypersensitivity or allergy to Sildenafil or Tadalafil.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method